"10.1371_journal.pone.0020226","plos one","2011-07-07T00:00:00Z","Douglas W McMillin; Jake Delmore; Joseph Negri; Melissa Ooi; Steffen Klippel; Chandrasekhar V Miduturu; Nathanael S Gray; Paul G Richardson; Kenneth C Anderson; Andrew L Kung; Constantine S Mitsiades","Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America; Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America; Department of Biological Chemistry and Molecular Pharmacology, Dana-Farber Cancer Institute, Department of Cancer Biology and Harvard Medical School, Boston, Massachusetts, United States of America; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Children's Hospital Boston, Boston, Massachusetts, United States of America","Conceived and designed the experiments: DWM ALK CSM. Performed the experiments: DWM JD JN MO ALK. Analyzed the data: DWM ALK CSM. Contributed reagents/materials/analysis tools: SK CVM NSG PGR KCA. Wrote the paper: DWM ALK CSM.","D.W.M. is an equity holder in Axios Biosciences. J.D., J.N., M.O., S.K., C.V.M., N.S.G., and A.L.K. have nothing to disclose. P.G.R. has received honoraria from Millennium and Celgene. K.C.A. has received research grants and honoraria from Millennium and Celgene. C.S.M. has received in the past Consultant honoraria from Millennium Pharmaceuticals, Novartis Pharmaceuticals, Bristol-Myers Squibb, Merck &Co., Kosan Pharmaceuticals, Celgene and Pharmion, licensing royalties from PharmaMar, and research funding from Amgen Pharmaceuticals, AVEO Pharma, EMD Serono, Sunesis, Gloucester Pharmaceuticals, and Johnson & Johnson.","2011","07","Douglas W McMillin","DWMM",11,TRUE,3,5,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
